NCT00420823View on ClinicalTrials.gov

A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

121

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2010

Conditions

Psychotic Disorders

Interventions

DRUG

Taurine 4g

Trial Locations (2)

3052

ORYGEN Youth Health, Melbourne

3168

RAPPS programme, Southern Health, Melbourne

Sponsors

Lead Sponsor

Melbourne Health

All Listed Sponsors

collaborator

Stanley Medical Research Institute

OTHER

collaborator

Southern Health

OTHER

lead

Melbourne Health

OTHER